Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.2K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

970
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
970

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.

Annals of the rheumatic diseases·2026
Same author

Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.

Rheumatology and therapy·2026
Same author

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.

Rheumatology (Oxford, England)·2026
Same author

Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritis.

Nature reviews. Rheumatology·2026
Same author

Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study.

Rheumatology and therapy·2026

Related Experiment Video

Updated: Apr 15, 2026

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints
10:10

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on: December 9, 2025

798

Cellular imaging in rheumatic diseases.

Robert A Benson1, Iain B McInnes1, James M Brewer1

  • 1Centre for Immunobiology, Institute of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

Nature Reviews. Rheumatology
|March 25, 2015
PubMed
Summary

Cellular imaging reveals immune response dynamics, crucial for understanding immune decisions and autoimmune diseases like rheumatoid arthritis (RA). This knowledge aids in developing targeted therapies for RA by analyzing aberrant cell interactions.

More Related Videos

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
07:15

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis

Published on: October 20, 2013

9.9K
Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
06:46

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent

Published on: May 8, 2017

9.4K

Related Experiment Videos

Last Updated: Apr 15, 2026

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints
10:10

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on: December 9, 2025

798
In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
07:15

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis

Published on: October 20, 2013

9.9K
Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
06:46

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent

Published on: May 8, 2017

9.4K

Area of Science:

  • Immunology
  • Cellular Biology
  • Medical Imaging

Background:

  • Cellular imaging allows real-time visualization of immune responses in vivo.
  • Immune cell interactions dictate immunological priming versus tolerance.
  • Dysregulation of immune balance can lead to autoimmune diseases, including rheumatoid arthritis (RA).

Purpose of the Study:

  • To understand the dynamics and anatomical context of cellular interactions during immune responses.
  • To dissect how cell interactions may be aberrant in autoimmune conditions.
  • To explore how cellular imaging can inform targeted therapies for RA.

Main Methods:

  • Real-time in vivo cellular imaging techniques.
  • Analysis of cellular interaction dynamics.
  • Investigation of anatomical context in immune responses.

Main Results:

  • Revealed previously unappreciated dynamics of cellular interactions in immune responses.
  • Highlighted the importance of cellular interaction context in immune system 'decisions'.
  • Provided insights into how immune cell interactions can be aberrant in autoimmunity.

Conclusions:

  • Understanding in vivo immune cell dynamics through imaging is critical for distinguishing immune tolerance from priming.
  • Aberrant cellular interactions observed in autoimmunity, such as in RA, can be dissected using advanced imaging.
  • Cellular imaging advancements offer potential for developing targeted therapies to restore immune homeostasis in RA patients.